1. Home
  2. CLBR vs SOPH Comparison

CLBR vs SOPH Comparison

Compare CLBR & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLBR
  • SOPH
  • Stock Information
  • Founded
  • CLBR 2023
  • SOPH 2011
  • Country
  • CLBR United States
  • SOPH Switzerland
  • Employees
  • CLBR N/A
  • SOPH N/A
  • Industry
  • CLBR
  • SOPH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CLBR
  • SOPH Health Care
  • Exchange
  • CLBR Nasdaq
  • SOPH Nasdaq
  • Market Cap
  • CLBR 240.1M
  • SOPH 226.6M
  • IPO Year
  • CLBR 2023
  • SOPH 2021
  • Fundamental
  • Price
  • CLBR $11.59
  • SOPH $3.39
  • Analyst Decision
  • CLBR
  • SOPH Strong Buy
  • Analyst Count
  • CLBR 0
  • SOPH 3
  • Target Price
  • CLBR N/A
  • SOPH $7.00
  • AVG Volume (30 Days)
  • CLBR 286.4K
  • SOPH 17.9K
  • Earning Date
  • CLBR 01-01-0001
  • SOPH 11-05-2024
  • Dividend Yield
  • CLBR N/A
  • SOPH N/A
  • EPS Growth
  • CLBR N/A
  • SOPH N/A
  • EPS
  • CLBR N/A
  • SOPH N/A
  • Revenue
  • CLBR N/A
  • SOPH $64,488,000.00
  • Revenue This Year
  • CLBR N/A
  • SOPH $7.20
  • Revenue Next Year
  • CLBR N/A
  • SOPH $15.71
  • P/E Ratio
  • CLBR $152.01
  • SOPH N/A
  • Revenue Growth
  • CLBR N/A
  • SOPH 9.85
  • 52 Week Low
  • CLBR $9.16
  • SOPH $2.70
  • 52 Week High
  • CLBR $12.28
  • SOPH $7.37
  • Technical
  • Relative Strength Index (RSI)
  • CLBR 75.88
  • SOPH 42.55
  • Support Level
  • CLBR $11.50
  • SOPH $3.20
  • Resistance Level
  • CLBR $12.28
  • SOPH $3.50
  • Average True Range (ATR)
  • CLBR 0.29
  • SOPH 0.17
  • MACD
  • CLBR 0.06
  • SOPH -0.00
  • Stochastic Oscillator
  • CLBR 77.38
  • SOPH 0.00

About CLBR Colombier Acquisition Corp. II

Colombier Acquisition Corp II is a blank check company.

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Share on Social Networks: